According to Insmed's latest financial reports and stock price the company's current Operating Margin is -250.21%. At the end of 2024 the company had an Operating Margin of -250.22%.
Year | Operating Margin | Change |
---|---|---|
2024 | -250.22% | 2.23% |
2023 | -244.76% | 25.07% |
2022 | -195.69% | -15.49% |
2021 | -231.57% | 30.08% |
2020 | -178.02% | -4.19% |
2019 | -185.80% | -94.36% |
2018 | -3,295.13% | |
2013 | -498.21% | |
2011 | -1,350.78% | 1370.86% |
2010 | -91.84% | -108.02% |
2009 | 1,145.54% | -955.41% |
2008 | -133.92% | -50.67% |
2007 | -271.47% | -95.05% |
2006 | -5,486.68% | -73.8% |
2005 | -20,941.98% | 4.61% |
2004 | -20,018.25% | 183.65% |
2003 | -7,057.33% | 278.86% |
2002 | -1,862.76% | -85.17% |
2001 | -12,557.09% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.